BOSTON--(BUSINESS WIRE)--Gelesis will deliver three poster presentations at ENDO, the Endocrine Society Annual Meeting, held in New Orleans from March 23-26.
LEHI, Utah--(BUSINESS WIRE)--Frelii Inc. has entered into a Memorandum of Understanding (MOU) with NewPath Health Care Solutions, Mercator Biologic and True DNA Story
SAN DIEGO--(BUSINESS WIRE)--CB Therapeutics is operating a new R&D and production facility in SoCal, accelerating its path to bringing pure therapeutic compounds to market
DUARTE, Calif.--(BUSINESS WIRE)--lt;a href="https://twitter.com/hashtag/CityofHope?src=hash" target="_blank"gt;#CityofHopelt;/agt;--City of Hope recently received $7.5 million in grant awards to study a rare type of blood cancer that affects the skin: cutaneous T cell lymphoma
TAMPA, Fla.--(BUSINESS WIRE)--Organics Announces Proposed Underwritten Public Offering
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Announces Cash Dividend of 16.4 Cents per Share
CINCINNATI--(BUSINESS WIRE)--HealthWarehouse.com, Inc. (OTC: HEWA) announced today that its net sales for 2018 increased 6% to $15,748,162 compared to $14,847,262 in 2017. The 2018 annual results benefited from a strong fourth quarter during which net sales increased 18% to $4,301,612 in 2018 compared to $3,632,511 during the same period in 2017. HealthWarehouse.com is a Verified Internet Pharmacy Practice Sites (VIPPS) accredited online and mail-order pharmacy authorized to sell and deliver pr
IRVINE, Calif.--(BUSINESS WIRE)--Endologix, Inc. (Nasdaq:ELGX) (the “Company”), a developer and marketer of innovative treatments for aortic disorders, announced today the grant of inducement equity awards to nine newly hired employees (the “Awardees”). The awards were approved by the Company’s Compensation Committee, which is comprised of independent Directors, on March 13, 2019, as an inducement material to the Awardees’ entry into employment with the Company, as permitted under NASDAQ Listin
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Vaxart, Inc., a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, today announced the closing of its previously announced registered direct offering of 1,200,000 shares of its common stock at a price of $2.50 per share. Total gross proceeds from the offering were $3.0 million, before deducting placement agent fees and estimated offering expenses. H.C. Wainwright &
CRANBURY, N.J.--(BUSINESS WIRE)--The American Journal of Managed Care® Announces Latest Institute for Value-Based Medicine® Meeting
STRASBOURG, France--(BUSINESS WIRE)--lt;a href="https://twitter.com/hashtag/Transgene?src=hash" target="_blank"gt;#Transgenelt;/agt;--Regulatory News: Transgene (Euronext Paris: TNG) (Paris:TNG), a biotech company that designs and develops virus-based immunotherapies to transform the fight against solid tumors and infectious diseases, publishes its financial results for 2018 and provides an update on its clinical and preclinical portfolio, and its technology platforms. Philippe Archinard, Chairman and Chief Executive Officer of Transgene, commented: “2018 was a year of intense activity for
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Syngenta Crop Challenge in Analytics, sponsored by INFORMS, announced finalists.
OAKLAND, Calif.--(BUSINESS WIRE)--lt;a href="https://twitter.com/hashtag/CWCI?src=hash" target="_blank"gt;#CWCIlt;/agt;--CWCI found shifts in the mix of California workers' comp prescriptions and in the total drug spend after the formulary took effect.
ANN ARBOR, Mich. & LANSING, Mich.--(BUSINESS WIRE)--MichBio announces annual Michigan Biosciences Day at the Capitol April 10, 2019 and seeks participants.
CHICAGO--(BUSINESS WIRE)--Pharma Logistics and PDM Healthcare jointly announce the offering of Pharma Logistics reverse pharmaceutical distribution services. Pharma Logistics’ services are focused on compliance, convenience and affordability, while offering insight and analytics on the pharmaceutical returns process. Founded in 1991, PDM Healthcare is a national healthcare service firm that provides group purchasing, supply chain management, business development, marketing/advertising, and educ
CHICAGO--(BUSINESS WIRE)--lt;a href="https://twitter.com/hashtag/AACR19?src=hash" target="_blank"gt;#AACR19lt;/agt;--Proteintech, the benchmark in antibodies, today announced the winners of the 2019 American Association for Cancer Research (AACR) Annual Meeting Travel Grant awards. Uday Pratap of University of Texas Health Science Center at San Antonio and Renzo Perales-Linares of the University of Pennsylvania have each been awarded $1,000 each to cover expenses to attend the 2019 Annual Meeting, being held March 29 – April 3 in Atlanta, GA. Choosing the best therapeutic strategy to
REDWOOD CITY, Calif.--(BUSINESS WIRE)--lt;a href="https://twitter.com/hashtag/aligners?src=hash" target="_blank"gt;#alignerslt;/agt;--uLab Systems Announces Partnership with Dental Assist to Expand Commercialization of Treatment Planning Software in Japan
DALLAS--(BUSINESS WIRE)--lt;a href="https://twitter.com/hashtag/CDMO?src=hash" target="_blank"gt;#CDMOlt;/agt;--Swiss American CDMO, a Dallas-based company that specializes in skin and wound care products, was recently named one of the top 10 CDMOs.
NASHVILLE, Tenn.--(BUSINESS WIRE)--axialHealthcare announces leadership transitions designed to meet the company’s increased operational needs and poise the organization for growth.
TORONTO--(BUSINESS WIRE)--DionyMed Brands Inc. Signs Binding Term Sheet to Acquire 1.83 Acre Southern California Cannabis Campus from MMAC
MADISON, Wis.--(BUSINESS WIRE)--lt;a href="https://twitter.com/hashtag/CRC?src=hash" target="_blank"gt;#CRClt;/agt;--Promega is donating $50,000 to colorectal cancer education during Colorectal Cancer Awareness Month and Lynch Syndrome Awareness Day (March 22).
CRANBURY, N.J.--(BUSINESS WIRE)--lt;a href="https://twitter.com/hashtag/CURE?src=hash" target="_blank"gt;#CURElt;/agt;--CURE Media Group Adds the Prostate Cancer Foundation to Its Strategic Alliance Partnership Program
STERLING, Kan.--(BUSINESS WIRE)--Genzada Pharmaceuticals USA Inc. (Genzada), a subsidiary of Ionics Life Sciences Limited, announced today that the first patient enrolled in its Phase 1 clinical trial for the oral therapeutic GZ17-6.02 received the first dose this week at HonorHealth Research Institute in Scottsdale, Ariz. Genzada’s GZ17-6.02 will be administered to patients with advanced solid cancers and lymphoma. The drug is derived in part from the black calla lily (arum palaestinum), a nat
SCOTTSDALE, Ariz.--(BUSINESS WIRE)--Magellan Health will open a free 24-hour crisis line for all individuals impacted by the floods in Nebraska.
SOMERSET, N.J.--(BUSINESS WIRE)--lt;a href="https://twitter.com/hashtag/HearingAid?src=hash" target="_blank"gt;#HearingAidlt;/agt;--Oticon sets a new standard in child hearing care with Oticon Opn Play, a hearing aid designed to meet the developmental needs of growing children.
WASHINGTON--(BUSINESS WIRE)--The Population Association of America (PAA) a professional, scientific society whose members conduct research on the implications of population change, will brief Congress March 28 on new immigrants in America. The briefing, led by immigration policy experts, will take a scientific look into the peoples making the journey to our country, their background, where they come from, and share research findings regarding the U.S. immigration experience. What: PAA Con
SOMERSET, N.J.--(BUSINESS WIRE)--lt;a href="https://twitter.com/hashtag/Hearing?src=hash" target="_blank"gt;#Hearinglt;/agt;--New Oticon Opn S hearing aids deliver more control and convenience to individuals with hearing loss.
MUNICH--(BUSINESS WIRE)--Brainlab, a global pioneer of software-driven medical technology, announced today the acquisition of Medineering, a developer of application-specific robotic technologies. With this move, Brainlab is driving the democratization of digital surgery with scalable solutions that expand clinical frontiers. This strategic move increases the depth of the Brainlab portfolio in cranial surgery and strengthens its offering in spinal surgery, contributing a powerful digital step i
NEWBURY PARK, Calif.--(BUSINESS WIRE)--Compulink previews new User Interface for its Ophthalmology SMART EHR at the Retina World Congress this week.
DEERFIELD, Ill.--(BUSINESS WIRE)--The Walgreens Flu Index™ is a weekly report developed to provide state- and market-specific information regarding flu activity, and ranks those states and markets experiencing the highest incidences of influenza across the country. Now in its fifth flu season, the Walgreens Flu Index was developed as a tool for consumers, health officials and the media to track flu activity in their area, and it continues to be an indicator of flu activity and important reminde
KNUTSFORD, England--(BUSINESS WIRE)--Fishawack continues to build best-in-class service offering with Dudnyk acquisition.
BALTIMORE--(BUSINESS WIRE)--Vixiar Medical Closes Financing Round
ROSEVILLE, Minn.--(BUSINESS WIRE)--lt;a href="https://twitter.com/hashtag/Cdiff?src=hash" target="_blank"gt;#Cdifflt;/agt;--Rebiotix and Ferring to highlight microbiome data from two recurrent C. diff Phase 2 clinical studies at the Gut Microbiota for Health World Summit.
LOUISVILLE, Ky.--(BUSINESS WIRE)--The ERP Biomarker Qualification Consortium was launched today by pharmaceutical industry members with the goal of qualifying event-related potential (ERP) biomarkers to aid the development of new investigational therapies for people with schizophrenia in accordance with FDA guidelines1. The Consortium, which brings together industry, academic and regulatory stakeholders, also aims to standardize ERP measurements so they are consistent across treatment centers a
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Cydan Expands Team to Accelerate Development of Innovative Treatments for Patients Living with Rare Diseases
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Nimbus Therapeutics appointed Alan Collis, Ph.D., and Jennifer Rocnik, Ph.D., two experts in drug discovery and development, to its leadership team.
LOS ANGELES--(BUSINESS WIRE)--Eos Biosciences Issued Patent for New Approach to Shuttle Therapeutics Across the Blood-Brain Barrier to Treat Brain Diseases
FORT MYERS, Fla.--(BUSINESS WIRE)--lt;a href="https://twitter.com/hashtag/AON?src=hash" target="_blank"gt;#AONlt;/agt;--American Oncology Network’s partner practices report positive results following the implementation of the network’s care management services.
BOSTON & COPENHAGEN, Denmark--(BUSINESS WIRE)--Alexion and Zealand Pharma Announce Collaboration to Discover and Develop Peptide Therapies for Complement-Mediated Diseases
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Oncolytic virus therapeutics-focused company Oncorus, Inc., announces an oral presentation on ONCR-177 at the upcoming AACR 2019 annual meeting.
THOUSAND OAKS, Calif.--(BUSINESS WIRE)--Dyve Bioscience Announces Positive Results from Pilot Study in Gout Pain at European Crystal Network Workshop 2019
PARIS & NEW YORK--(BUSINESS WIRE)--Vivet Therapeutics (“Vivet”), a privately held gene therapy biotech company dedicated to developing gene therapy treatments for inherited liver disorders with high unmet medical need, and Pfizer Inc. (NYSE: PFE) announced today that Pfizer has acquired a 15% equity interest in Vivet and secured an exclusive option to acquire all outstanding shares. Pfizer and Vivet will collaborate on the development of VTX-801, Vivet’s proprietary treatment for Wilson disease
BOSTON & SOLNA, Sweden--(BUSINESS WIRE)--Alexion and Affibody Announce Partnership to Co-Develop Anti-FcRn Affibody® Molecule
KENILWORTH, N.J., and SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--lt;a href="https://twitter.com/search?q=%24MRK&src=ctag" target="_blank"gt;$MRKlt;/agt; lt;a href="https://twitter.com/hashtag/MRK?src=hash" target="_blank"gt;#MRKlt;/agt;--Merck and NGM Bio Announce Extension of Broad, Multi-Year Strategic Collaboration to 2022
LOS ANGELES--(BUSINESS WIRE)--lt;a href="https://twitter.com/hashtag/deepmedicine?src=hash" target="_blank"gt;#deepmedicinelt;/agt;--Pepperdine Graziadio Business School to host it 5th annual Future of Healthcare Symposium on March 21, 2019 at The Ritz-Carlton in Marina del Rey
PITTSBURGH--(BUSINESS WIRE)--lt;a href="https://twitter.com/hashtag/asthma?src=hash" target="_blank"gt;#asthmalt;/agt;--Knopp Biosciences LLC, a privately held drug discovery and development company focused on delivering breakthrough treatments for inflammatory and neurological diseases with high unmet need, today announced a collaboration with a consortium of leading medical researchers in the United Kingdom to evaluate the ability of Knopp’s lead drug candidate, dexpramipexole, to reduce exacerbations in people with severe eosinophilic asthma. The project is chiefly funded by the N